XM does not provide services to residents of the United States of America.
I
I

Illumina

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Nasdaq top and bottom performing stocks at about 12:02 p.m. EST

BUZZ - Nasdaq top and bottom performing stocks at about 12:02 p.m. EST Nasdaq 100 .NDX Top Performers Percent Change Palo Alto Networks Inc PANW.OQ +9.7% Micron Technology Inc MU.OQ +6.5% Tesla Inc TSLA.OQ +4.5% Coca-Cola Europacific Partners PLC CCEP.OQ +3.8% Illumina Inc ILMN.OQ +3.7% Bottom Performers Percent Change Moderna Inc MRNA.OQ -4.3% Alphabet Inc GOOGL.OQ -3.7% Alphabet Inc GOOG.OQ -3.6% Airbnb Inc ABNB.OQ -2.3% DoorDash Inc DASH.OQ -2.3% The Nasdaq 100 .NDX gained 43.95 points, or 0.
G
I
M
T
U

S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST S&P 500 .SPX Top Performers Percent Change Palo Alto Networks Inc PANW.OQ +10.2% Micron Technology Inc MU.OQ +6.6% Domino's Pizza Inc DPZ.N +6.5% Tesla Inc TSLA.OQ +4.6% Illumina Inc ILMN.OQ +4.1% Bottom Performers Percent Change Insulet Corp PODD.OQ -6.7% Moderna Inc MRNA.OQ -
G
I
M
T
U

Carl Icahn's investment firm names insider Andrew Teno as CEO

UPDATE 3-Icahn Enterprises warns of drop in asset value, names insider Teno CEO Recasts paragraph 1 with net asset value and share movement, adds background throughout Feb 21 (Reuters) - Icahn Enterprises IEP.O on Wednesday warned of a sequential decline in its indicative net asset value in the fourth quarter, sending shares of the investment firm, which named insider Andrew Teno as its CEO, down 11%.
I

Illumina Implemented Cost Reduction Initiative in Q2 Included Workforce Reductions, Consolidation Of Certain Facilities

BRIEF-Illumina Implemented Cost Reduction Initiative in Q2 Included Workforce Reductions, Consolidation Of Certain Facilities Feb 16 (Reuters) - Illumina Inc ILMN.O : ILLUMINA- IN Q2 2023 IMPLEMENTED COST REDUCTION INITIATIVE INCLUDED WORKFORCE REDUCTIONS, CONSOLIDATION OF CERTAIN FACILITIES TO REDUCE EXPENSES ILLUMINA- ON JAN 18, GOT CIVIL INVESTIGATIVE DEMAND FROM U.S.
I

Illumina, already facing pressure from Icahn, saw other activists at year end

Illumina, already facing pressure from Icahn, saw other activists at year end By Svea Herbst-Bayliss NEW YORK, Feb 14 (Reuters) - Gene-sequencing company Illumina ILMN.O , which was pushed to make changes by Carl Icahn last year, had two additional activist investors in its stock at the end of the fourth quarter, according to new regulatory filings. Keith Meister's Corvex Management disclosed buying Illumina stock during the last three months of 2023 and owning 730,084 shares on Dec.
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.